AA
IONS icon

Ancora Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Ancora Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$176K Sell
2,215
-176
-7% -$13.2K ﹤0.01% 755
2026
Q1 		$180K Buy
2,391
+49
+2% +$3.87K ﹤0.01% 739
2025
Q4 		$185K Buy
2,342
+205
+10% +$15.4K ﹤0.01% 758
2025
Q3 		$140K Buy
2,137
+137
+7% +$6.69K ﹤0.01% 794
2025
Q2 		$79K Hold
2,000
– – ﹤0.01% 923
2025
Q1 		$60.3K Buy
+2,000
New +$65.5K ﹤0.01% 967

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Ancora Advisors's IONS Position: Q2 2026 in Review

Ancora Advisors reduced its Ionis Pharmaceuticals (IONS) stake by 7.4% in Q2 2026, selling an estimated $13.2K and leaving 2,215 shares worth $176K. The position accounts for ﹤0.01% of the portfolio, ranked #755.

Ancora Advisors first reported a position in IONS in Q1 2025 and has held it in 6 quarters since. The position peaked at $185K in Q4 2025. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Ancora Advisors held 2,215 shares of Ionis Pharmaceuticals worth $176K as of Q2 2026.
  • Ancora Advisors sold 176 Ionis Pharmaceuticals shares in Q2 2026, an estimated $13.2K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Ancora Advisors's portfolio in Q2 2026, its #755 holding.
  • Ancora Advisors first reported a position in Ionis Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Ancora Advisors's Ionis Pharmaceuticals position peaked at $185K in Q4 2025.
  • 515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.